Related Experiment Video

Updated: May 23, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Non-alcoholic fatty liver disease in children

Wojciech Janczyk1, Piotr Socha

  • 1Department of Gastroenterology, Hepatology and Eating Disorders, The Children's Memorial Health Institute, Warsaw, Poland. w.janczyk@czd.pl

Clinics and Research in Hepatology and Gastroenterology
|April 24, 2012
PubMed

Insights

Non-alcoholic fatty liver disease (NAFLD) is rising in children, often linked to obesity. Lifestyle changes are key treatments, while drug therapies are still being explored for pediatric NAFLD management.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Public Health

Background:

  • Non-alcoholic fatty liver disease (NAFLD) prevalence is increasing in children, coinciding with rising obesity rates.
  • Current diagnostic approaches for pediatric NAFLD include liver function tests, insulin resistance markers, and imaging like ultrasonography and MRI.
  • It is crucial to rule out other liver conditions, such as Wilson disease, in children presenting with liver issues.

Purpose of the Study:

  • To review the current landscape of pediatric non-alcoholic fatty liver disease.
  • To outline diagnostic strategies and indications for liver biopsy in children.
  • To discuss current and emerging treatment modalities for pediatric NAFLD.

Main Methods:

  • Literature review of diagnostic tools and treatment strategies for pediatric NAFLD.
  • Analysis of indications for liver biopsy in pediatric cases.
  • Summary of current first-line treatments and investigational drug therapies.

Main Results:

  • Various non-invasive markers like transaminases, insulin resistance tests, ultrasonography, and MRI are used to assess steatosis.
  • Liver biopsy is reserved for specific pediatric cases, including young children, those with a family history of severe disease, inconclusive non-invasive tests, suspected advanced fibrosis, or persistent hypertransaminasemia despite weight loss.
  • Weight reduction and lifestyle modifications are the primary treatment strategies.

Conclusions:

  • NAFLD in children is a growing concern requiring careful diagnosis and management.
  • Non-invasive methods are valuable, but liver biopsy remains important for selected pediatric patients.
  • Lifestyle interventions are the cornerstone of NAFLD treatment in children, with pharmacotherapy under active investigation.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...